Stromal Gremlin expression in colorectal cancer, as determined by GREM1 in situ hybridization, was found to be associated with a less advanced cancer stage, decreased lymphovascular invasion and improved recurrence-free and overall survival [47]. The gene discussed is GREM1; the disease is cancer.